Increased Tumor Mutation Burden Levels and Sensitivity of Non-Small Cell Lung Cancer to PD-L1 Blockade. Aslan V, Yazici O, Ozdemir N. JAMA Oncol 2023 Feb 2. doi: 10.1001/jamaoncol.2022.7586.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Aslan V, Yazici O, Ozdemir N. Increased Tumor Mutation Burden Levels and Sensitivity of Non-Small Cell Lung Cancer to PD-L1 Blockade. JAMA Oncol 2023 Feb 2. doi: 10.1001/jamaoncol.2022.7586.
PMID: 36729466